Pharma Ventures subsidiary acquired By IMS Health
IMS Health strengthens its business sale and acquisition capabilities with PharmaDeals, enhancing analytics and market insights for the pharmaceutical industry.
Strengthening Syndicated Analytics with Strategic Acquisition
IMS Health has taken a significant step in expanding its business intelligence capabilities with the acquisition of PharmaDeals Ltd.
This move enhances IMS Health’s syndicated, web-based analytics offerings, strengthening its role as a leader in providing critical insights for the pharmaceutical industry.
PharmaDeals, a subsidiary of PharmaVentures Ltd., is widely recognised for its extensive online database of business transactions, licensing agreements, and mergers and acquisitions (M&A) within the pharmaceutical sector. The platform houses more than 46,000 records and 16 years of historical data, making it a gold standard resource for transaction intelligence.
Enhancing Market Insights for Smarter Decision-Making
The integration of PharmaDeals into IMS Health’s analytics suite offers significant benefits to healthcare and pharmaceutical clients. By combining PharmaDeals’ transaction insights with IMS’s advanced competitive intelligence, clients gain enhanced market assessment, forecasting, and portfolio management tools. These data-driven insights will aid pharmaceutical companies in analysing market trends, evaluating partnership opportunities, and optimising business sale and acquisition strategies.
Anne Delaney, General Manager at IMS Health, emphasised the importance of this acquisition in delivering high-value insights. “To properly assess licensing and partnership opportunities, businesses need a comprehensive view of transactions within the context of real-world evidence. The addition of PharmaDeals allows us to offer a more holistic approach to business decision-making as the industry evolves.”
Expanding PharmaVentures’ Core M&A Services
PharmaVentures Ltd., the parent company of PharmaDeals, has built a strong reputation in life sciences transaction advisory services. The acquisition enables PharmaVentures to focus on expanding its core business in M&A and licensing advisory, a sector that has seen substantial growth in recent years.
Dr. Fintan Walton, CEO of PharmaVentures, stated, “PharmaDeals has set the industry benchmark for transaction data quality and depth. Integrating with IMS Health will unlock new possibilities for decision-making, while PharmaVentures can now dedicate more resources to its expanding M&A and divestment services.”
Strengthening IMS Health’s Global Position
With operations in over 100 countries and more than five decades of experience, IMS Health remains a premier provider of information, services, and technology for the healthcare sector. By incorporating PharmaDeals’ robust transaction database, IMS Health reinforces its commitment to delivering cutting-edge solutions for pharmaceutical businesses navigating the complex landscape of acquisitions, partnerships, and competitive market dynamics.
Key Acquisitions That Shaped IMS Health
- Founded in 1954, IMS Health has a long history of strategic mergers and acquisitions, expanding its expertise in healthcare analytics and information services.
- 1998: Spun out from parent company Cognizant Corporation to become an independent entity.
- Early 2000s Expansion: Acquired Cambridge Pharma Consultancy and Rosenblatt Klauber Group (2002); purchased PharMetrics (2005) for patient-centric integrated claims data.
- 2010 Delisting: Taken private for $5.2 billion by TPG Capital, CPPIB, and Leonard Green & Partners.
- Further Acquisitions (2011-2015): SDI Health USA, Pharma Ventures UK, Forcea (Belgium), Healthcare Data Solutions, and Dateline Software UK.
- 2016 Merger: Combined with Quintiles to form QuintilesIMS, later rebranded as IQVIA (2017), a global leader in healthcare analytics and contract research services.
Mark Sapsford advised the shareholders of Pharma Ventures on the sale of the business.
More healthcare M&A deal news: Pharmacy audit software Pharm DUR acquired by ACS Inc.
We'd love to hear your story
Let's chat about your future plans. We can help you get clear on where you and your business are going.
